Pretty on the Inside

While new technologies in the fields of proteomics and genomics appear almost daily, histotechnology has remained largely unchanged since its development in the mid-1800s. Tissues are fixed, embedded in wax, sectioned, and stained as needed--a labor-intensive process that generates two-dimensional glass slides that must be viewed one at a time. An anatomical pathologist by training, Russell Kerschmann, founder and president of Corte Madera, Calif.-based Resolution Sciences Corp., is intimately f

Written byAileen Constans
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

After going on to practice pathology, Kerschmann began to experiment with methods of generating three-dimensional images of the cubic-millimeter-sized samples studied in pathology labs. The resulting technology is called Digital Volumetric Imaging, or DVI. To use DVI, the fixed sample is stained and then embedded in a black polymer. Next, the block is mounted on a microtome, an image is captured directly off the cut surface of the block using a CCD camera, a section is cut to the depth of the first image, and the process is repeated, about 1,000 times on average. The "optical thickness" of each section is controlled by the degree of blackness of the polymer, while interference from the depth of the sample is eliminated by the opacity of the polymer. Because no slides are made and the sectioning is automated, thousands of images can be captured from a sample, allowing micron-range resolution three-dimensional images ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies